Novartis boss laments Zolgensma delay

By Megan Brodie 3 years ago | In Cell and gene therapies, Products, Regulatory
  • 3 years ago

23 June 2021 More than 20 Australian babies with Spinal Muscular Atrophy (SMA) have received…

This is subscriber-only content. Please login to continue reading.